5:49 PM
 | 
Apr 29, 2013
 |  BC Extra  |  Financial News

Auxilium slips on 1Q13 results, Actient acquisition

Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) fell $2.03 (13%) to $14 on Monday after reporting 1Q13 revenues that missed the Street and disclosing it acquired urology company Actient Pharmaceuticals LLC (Lake Forest, Ill.) for $585 million in cash up front, plus warrants and up to $50 million in revenue-dependent milestones. Auxilium reported a...

Read the full 244 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >